Associated Papers
Discovery of Drugs Targeting Mutant p53 and Progress in Nano-Enabled Therapeutic Strategy for p53-Mutated Cancers.
Zhang N et al.
Biomolecules, 2025
Germline variants in UNC13D and AP3B1 are enriched in COVID-19 patients experiencing severe cytokine storms.
Luo H et al.
European Journal of Human Genetics : Ejhg, 2021
33867526 (PubMed )
Supplement: 41431_2021_886_MOESM2_ESM.xlsx › TableS4
MLPA and DNA index improve the molecular diagnosis of childhood B-cell acute lymphoblastic leukemia.
Yu CH et al.
Scientific Reports, 2020
Integrative genomic analysis focused on cell cycle genes for MYC-driven aggressive mature B-cell lymphoma.
Yamashita T et al.
Journal of Clinical and Experimental Hematopathology : Jceh, 2020
32981916 (PubMed )
Supplement: jslrt-60-87-s001.pdf
Profiling of gene expression changes caused by p53 gain-of-function mutant alleles in prostate cancer cells.
Tepper CG et al.
The Prostate, 2005
Discrimination of single amino acid mutations of the p53 protein by means of deterministic singularities of recurrence quantification analysis.
Porrello A et al.
Proteins, 2004
Select a paper to view details